BACKGROUND AND OBJECTIVES: Genes encoding protein C anticoagulant pathways are candidates for atherothrombotic and other aging-related disorders. METHODS: Using a tagSNP approach, and data from the Cardiovascular Health Study (CHS), we assessed associations of common polymorphisms of PROC, PROS1 and PROCR with: (i) plasma protein C, soluble protein C endothelial receptor (sEPCR) and protein S levels measured in a subsample of 336 participants at study entry; and (ii) risk of incident clinical outcomes [coronary heart disease (CHD), stroke, and mortality] in 4547 participants during follow-up. Secondarily, we explored associations between plasma protein C, protein S and sEPCR levels and other candidate genes involved in thrombosis, inflammation, and aging. RESULTS: The PROCR Ser219Gly polymorphism (rs867186) was strongly associated with higher sEPCR levels, explaining 75% of the phenotypic variation. The PROCR Ser219Gly variant was also associated with higher levels of circulating protein C antigen. An IL10 polymorphism was associated with higher free protein S levels. The minor alleles of PROC rs2069901 and PROS1 rs4857343 were weakly associated with lower protein C and free protein S levels, respectively. There was no association between PROCR Ser219Gly and risk of CHD, stroke, or mortality. The minor allele of another common PROCR tagSNP, rs2069948, was associated with lymphoid PROCR mRNA expression and with increased risk of incident stroke and all-cause mortality, and decreased healthy survival during follow-up. CONCLUSIONS: A common PROCR variant may be associated with decreased healthy survival in older adults. Additional studies are warranted to establish the role of PROCR variants in ischemic and aging-related disorders.
BACKGROUND AND OBJECTIVES: Genes encoding protein C anticoagulant pathways are candidates for atherothrombotic and other aging-related disorders. METHODS: Using a tagSNP approach, and data from the Cardiovascular Health Study (CHS), we assessed associations of common polymorphisms of PROC, PROS1 and PROCR with: (i) plasma protein C, soluble protein C endothelial receptor (sEPCR) and protein S levels measured in a subsample of 336 participants at study entry; and (ii) risk of incident clinical outcomes [coronary heart disease (CHD), stroke, and mortality] in 4547 participants during follow-up. Secondarily, we explored associations between plasma protein C, protein S and sEPCR levels and other candidate genes involved in thrombosis, inflammation, and aging. RESULTS: The PROCR Ser219Gly polymorphism (rs867186) was strongly associated with higher sEPCR levels, explaining 75% of the phenotypic variation. The PROCR Ser219Gly variant was also associated with higher levels of circulating protein C antigen. An IL10 polymorphism was associated with higher free protein S levels. The minor alleles of PROC rs2069901 and PROS1rs4857343 were weakly associated with lower protein C and free protein S levels, respectively. There was no association between PROCR Ser219Gly and risk of CHD, stroke, or mortality. The minor allele of another common PROCR tagSNP, rs2069948, was associated with lymphoid PROCR mRNA expression and with increased risk of incident stroke and all-cause mortality, and decreased healthy survival during follow-up. CONCLUSIONS: A common PROCR variant may be associated with decreased healthy survival in older adults. Additional studies are warranted to establish the role of PROCR variants in ischemic and aging-related disorders.
Authors: M Aiach; V Nicaud; M Alhenc-Gelas; S Gandrille; E Arnaud; J Amiral; L Guize; J N Fiessinger; J Emmerich Journal: Arterioscler Thromb Vasc Biol Date: 1999-06 Impact factor: 8.311
Authors: Alfonso Buil; José Manuel Soria; Juan Carlos Souto; Laura Almasy; Mark Lathrop; John Blangero; Jordi Fontcuberta Journal: Arterioscler Thromb Vasc Biol Date: 2004-05-13 Impact factor: 8.311
Authors: P A Sakkinen; M Cushman; B M Psaty; L H Kuller; S P Bajaj; A K Sabharwal; R Boineau; E Macy; R P Tracy Journal: Thromb Haemost Date: 1998-07 Impact factor: 5.249
Authors: J Duchemin; S Gandrille; D Borgel; P Feurgard; M Alhenc-Gelas; C Matheron; M Dreyfus; E Dupuy; I Juhan-Vague; M Aiach Journal: Blood Date: 1995-11-01 Impact factor: 22.113
Authors: S Uitte de Willige; V Van Marion; F R Rosendaal; H L Vos; M C H de Visser; R M Bertina Journal: J Thromb Haemost Date: 2004-08 Impact factor: 5.824
Authors: Weihong Tang; Christine Schwienbacher; Lorna M Lopez; Yoav Ben-Shlomo; Tiphaine Oudot-Mellakh; Andrew D Johnson; Nilesh J Samani; Saonli Basu; Martin Gögele; Gail Davies; Gordon D O Lowe; David-Alexandre Tregouet; Adrian Tan; James S Pankow; Albert Tenesa; Daniel Levy; Claudia B Volpato; Ann Rumley; Alan J Gow; Cosetta Minelli; John W G Yarnell; David J Porteous; John M Starr; John Gallacher; Eric Boerwinkle; Peter M Visscher; Peter P Pramstaller; Mary Cushman; Valur Emilsson; Andrew S Plump; Nena Matijevic; Pierre-Emmanuel Morange; Ian J Deary; Andrew A Hicks; Aaron R Folsom Journal: Am J Hum Genet Date: 2012-06-14 Impact factor: 11.025
Authors: Weihong Tang; Saonli Basu; Xiaoxiao Kong; James S Pankow; Nena Aleksic; Adrian Tan; Mary Cushman; Eric Boerwinkle; Aaron R Folsom Journal: Blood Date: 2010-08-27 Impact factor: 22.113
Authors: Kira C Taylor; Leslie A Lange; Delilah Zabaneh; Ethan Lange; Brendan J Keating; Weihong Tang; Nicholas L Smith; Joseph A Delaney; Meena Kumari; Aroon Hingorani; Kari E North; Mika Kivimaki; Russell P Tracy; Christopher J O'Donnell; Aaron R Folsom; David Green; Steve E Humphries; Alexander P Reiner Journal: Hum Mol Genet Date: 2011-06-15 Impact factor: 6.150
Authors: M Shahzeb Munir; Lu-Chen Weng; Weihong Tang; Saonli Basu; James S Pankow; Nena Matijevic; Mary Cushman; Eric Boerwinkle; Aaron R Folsom Journal: Genet Epidemiol Date: 2014-11-05 Impact factor: 2.135
Authors: Miriam A Mosing; Karin J H Verweij; Sarah E Medland; Jodie Painter; Scott D Gordon; Andrew C Heath; Pamela A Madden; Grant W Montgomery; Nicholas G Martin Journal: Twin Res Hum Genet Date: 2010-08 Impact factor: 1.587
Authors: Jessica Dennis; Candice Y Johnson; Adeniyi Samuel Adediran; Mariza de Andrade; John A Heit; Pierre-Emmanuel Morange; David-Alexandre Trégouët; France Gagnon Journal: Blood Date: 2012-01-17 Impact factor: 22.113
Authors: C Y Vossen; B P Koeleman; S J Hasstedt; I J Nijman; I J Renkens; P W Callas; F R Rosendaal; E G Bovill Journal: J Thromb Haemost Date: 2013-04 Impact factor: 5.824
Authors: N C Olson; L M Raffield; L A Lange; E M Lange; W T Longstreth; G Chauhan; S Debette; S Seshadri; A P Reiner; R P Tracy Journal: J Thromb Haemost Date: 2017-12-08 Impact factor: 5.824